Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Published Online
on December 28, 2006

Stroke. 2006
Published online before print December 28, 2006, doi: 10.1161/01.STR.0000254463.24655.14
A more recent version of this article appeared on February 1, 2007
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
38/2/367    most recent
01.STR.0000254463.24655.14v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shyu, W.-C.
Right arrow Articles by Li, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shyu, W.-C.
Right arrow Articles by Li, H.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*IRON
Medline Plus Health Information
*MRI Scans
Related Collections
Right arrow Behavioral Changes and Stroke
Right arrow Emergency treatment of Stroke
Right arrow Pathology of Stroke
Right arrow Rehabilitation, Stroke

Submitted on April 7, 2006
Revised on August 16, 2006
Accepted on September 10, 2006

Efficient Tracking of Non-Iron-Labeled Mesenchymal Stem Cells with Serial MRI in Chronic Stroke Rats

Woei-Cherng Shyu MD, PhD; Chie-Pein Chen MD, PhD; Shinn-Zong Lin MD, PhD; Yih-Jing Lee PhD; and Hung Li PhD*

From Department of Neurology (W.-C.S., S.-Z.L.), Neuro-Medical Scientific Center, Tzu-Chi Buddhist General Hospital, Tzu-Chi University, Hualien, Taiwan; Departments of Obstetrics and Gynecology (C.-P.C.), Mackay Memorial Hospital, Taipei, Taiwan; School of Medicine (Y.-J.L.), Fu-Jen Catholic University, Taipei, Taiwan; Institute of Molecular Biology (H.L.), Academia Sinica, Taipei, Taiwan; Department of Medical Research (H.L.), Mackay Memorial Hospital, Taipei, Taiwan.

* To whom correspondence should be addressed. E-mail: hungli{at}ccvax.sinica.edu.tw.

Background and Purpose--Although stem cell-based treatments for neurodegenerative diseases have advanced rapidly, there is currently no clinically available method to monitor the fate of transplanted cells in the brain.

Methods--To use magnetic resonance imaging for tracking transplanted stem cells in the ischemic rat brain, we used the cellular labeling substance Effectene to transfect a standard contrast agent (Gd-DTPA) into immortalized human bone marrow stromal cells.

Results--The transfection efficiency of this method was up to 90%, which is substantially better than pure spontaneous endocytosis or other transfection agents. In addition, cellular uptake of Gd-DTPA in vitro was maintained for >28 days. Therefore, we could follow transplanted stem cell migration and homing into the penumbric area. Using double immunofluorescence, the transplanted cells were seen to differentiate into glial cells, neurons and vascular endothelial cells. Cortical neurochemical activity as evaluated by proton magnetic resonance spectroscopy (1H-MRS) also increased considerably after immortalized human bone marrow stromal cell transplantation.

Conclusion--This method of tracking immortalized human bone marrow stromal cells is highly efficient and allows for nontoxic labeling of cells.
Key words: Effectene • Gd-DTPA • immortalized human bone marrow stromal cells • in vivo monitoring • magnetic resonance imaging






Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search
Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited.